This effect is thought to be mediated by increasing natriuresis (35) and vasorelaxation in the renal vasculature (36)
While GLP-1 treatments have been approved by the FDA for weight management, and not just for diabetics, there are still some hurdles people have to overcome, like meeting certain BMI requirements, finding a licensed provider, or covering expensive out-of-pocket costs for the treatment if their insurance provider doesn't cover weight loss treatments
Boston University and UMass Memorial Health said they will stop covering GLP-1s for weight loss next year, with the latter saying it spent $20 million on the drugs just in the past year
Gut-driven GLP-1 support with 11g fiber and clinically studied Akkermansia for fullness and appetite control
Patients without insurance, or without Wegovy coverage through their insurance plan, have access to self-pay medication options like Wegovy ($349/mo.), Zepbound vials (starting at $349/mo.) and more through this program if eligible
Secure traceability from our lab to your bench